Healthy pregnancy in a woman with GH-secreting pituitary macroadenoma treated with pasireotide

Ann Endocrinol (Paris). 2023 Aug;84(4):427-429. doi: 10.1016/j.ando.2023.01.006. Epub 2023 Feb 1.

Authors

Mahaut Petyt¹, Solange Grunenwald¹, Céline Mouly¹, Julie Benoit¹, Philippe Caron²

Affiliations

¹ Service d'endocrinologie, maladies métaboliques et nutrition, pôle crdiovsculaire et mtabolique, CHU de Larrey, 24, chemin de Pouvourville, TSA 30030, 31059 Toulouse cedex, France.
² Service d'endocrinologie, maladies métaboliques et nutrition, pôle crdiovsculaire et mtabolique, CHU de Larrey, 24, chemin de Pouvourville, TSA 30030, 31059 Toulouse cedex, France. Electronic address: caron.p@chu-toulouse.fr.

PMID: 36736770
DOI: 10.1016/j.ando.2023.01.006

No abstract available

Keywords: Acromegaly; Fetal malformation; Gestational diabetes; Pasireotide; Pregnancy; Pregnancy-induced hypertension.

Publication types

Case Reports
Letter

MeSH terms

Acromegaly*
Female
Growth Hormone-Secreting Pituitary Adenoma*
Humans
Insulin-Like Growth Factor I
Pituitary Neoplasms* / complications
Pituitary Neoplasms* / drug therapy
Pregnancy
Somatostatin / therapeutic use

Substances

Insulin-Like Growth Factor I
pasireotide
Somatostatin